From the report from Evans and Partners, if I as a patient and...

From the report from Evans and Partners, if I as a patient and required to pay in excess of $300 and a new product becomes available, even out of pocket costs of approx $75, of course I would want to spend less, and less side effects is a bonus, so wouldn't I swap? Times are tough, and saving a few hundreds a month goes a long way

I know a some ppl are worried about a potential CR, but how much money in the bank would they need to be secure? How long would it take for payments to start coming in from these insurance deals?

I could see situation as a number of years ago, for speed, CR to sophs only, get the money they need, I don't want to see more dilution occur, but I personally hope they hold on for the first quarter of sales.

The other pipelines should then get a mention again, and start attributing some value